Annual Retained Earnings
-$247.60 M
-$89.22 M-56.33%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual retained earnings is -$247.60 million, with the most recent change of -$89.22 million (-56.33%) on December 31, 2023.
- During the last 3 years, TCRX annual retained earnings has fallen by -$204.06 million (-468.76%).
- TCRX annual retained earnings is now -1322.48% below its all-time high of -$17.41 million, reached on December 31, 2019.
Performance
TCRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$339.29 M
-$29.89 M-9.66%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly retained earnings is -$339.29 million, with the most recent change of -$29.89 million (-9.66%) on September 30, 2024.
- Over the past year, TCRX quarterly retained earnings has dropped by -$111.30 million (-48.82%).
- TCRX quarterly retained earnings is now -679.38% below its all-time high of -$43.53 million, reached on December 1, 2020.
Performance
TCRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TCRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.3% | -48.8% |
| 3 y3 years | -468.8% | -48.8% |
| 5 y5 years | -1322.5% | -48.8% |
TCRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -168.7% | at low | -268.2% | at low |
| 5 y | 5-year | -1322.5% | at low | -679.4% | at low |
| alltime | all time | -1322.5% | at low | -679.4% | at low |
TScan Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$339.29 M(+9.7%) |
| Jun 2024 | - | -$309.40 M(+11.4%) |
| Mar 2024 | - | -$277.74 M(+12.2%) |
| Dec 2023 | -$247.60 M(+56.3%) | -$247.60 M(+8.6%) |
| Sep 2023 | - | -$227.98 M(+11.2%) |
| Jun 2023 | - | -$204.99 M(+13.3%) |
| Mar 2023 | - | -$180.94 M(+14.2%) |
| Dec 2022 | -$158.38 M | -$158.38 M(+13.4%) |
| Sep 2022 | - | -$139.66 M(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$123.41 M(+13.9%) |
| Mar 2022 | - | -$108.31 M(+17.5%) |
| Dec 2021 | -$92.16 M(+111.7%) | -$92.16 M(+18.2%) |
| Sep 2021 | - | -$77.96 M(+25.5%) |
| Jun 2021 | - | -$62.12 M(+20.7%) |
| Mar 2021 | - | -$51.45 M(+18.2%) |
| Dec 2020 | -$43.53 M(+150.1%) | - |
| Dec 2020 | - | -$43.53 M |
| Dec 2019 | -$17.41 M | - |
FAQ
- What is TScan Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for TScan Therapeutics?
- What is TScan Therapeutics annual retained earnings year-on-year change?
- What is TScan Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for TScan Therapeutics?
- What is TScan Therapeutics quarterly retained earnings year-on-year change?
What is TScan Therapeutics annual retained earnings?
The current annual retained earnings of TCRX is -$247.60 M
What is the all time high annual retained earnings for TScan Therapeutics?
TScan Therapeutics all-time high annual retained earnings is -$17.41 M
What is TScan Therapeutics annual retained earnings year-on-year change?
Over the past year, TCRX annual retained earnings has changed by -$89.22 M (-56.33%)
What is TScan Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TCRX is -$339.29 M
What is the all time high quarterly retained earnings for TScan Therapeutics?
TScan Therapeutics all-time high quarterly retained earnings is -$43.53 M
What is TScan Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TCRX quarterly retained earnings has changed by -$111.30 M (-48.82%)